---
figid: PMC9259916__ic-54-353-g001
pmcid: PMC9259916
image_filename: ic-54-353-g001.jpg
figure_link: /pmc/articles/PMC9259916/figure/F1/
number: Figure 1
figure_title: Application flow chart of the clinical pathway (CP). (A) CP for asymptomatic
  patients (CP-A). (B) CP for symptomatic patients (CP-S). The CP was last updated
  on March 25, 2022
caption: aImmunocompromised patients, pregnant women, dialysis patients, cognitive
  dysfunction such as dementia.bApplied to patients who are confirmed as infected
  with major variants of COVID-19, which are predefined by Korea Disease Control and
  Prevention Agency (KDCA). Others condition, such as immunocompromised patients,
  can be applied according the policy of institution.CConducted after 24-hour interval
  from the previous test.PCR, polymerase chain reaction; CXR, chest X-ray; COVID-19,
  coronavirus disease 2019.
article_title: Development and Roll-Out of A Coronavirus Disease 2019 Clinical Pathway
  for Standardized Qualified Care in Public Hospitals in Korea.
citation: Mi Young Kwak, et al. Infect Chemother. 2022 Jun;54(2):353-359.
year: '2022'

doi: 10.3947/ic.2022.0026
journal_title: Infection & Chemotherapy
journal_nlm_ta: Infect Chemother
publisher_name: The Korean Society of Infectious Diseases; Korean Society for Antimicrobial
  Therapy; The Korean Society for AIDS

keywords:
- SARS-CoV-2
- COVID-19
- Pandemics
- Clinical pathways
- Hospitals, public

---
